DK0821693T3 - Nye DNA-sekvenser fra human cytomegalovirus (HCMV) - Google Patents

Nye DNA-sekvenser fra human cytomegalovirus (HCMV)

Info

Publication number
DK0821693T3
DK0821693T3 DK96910560T DK96910560T DK0821693T3 DK 0821693 T3 DK0821693 T3 DK 0821693T3 DK 96910560 T DK96910560 T DK 96910560T DK 96910560 T DK96910560 T DK 96910560T DK 0821693 T3 DK0821693 T3 DK 0821693T3
Authority
DK
Denmark
Prior art keywords
hcmv
dna sequences
human cytomegalovirus
new human
sequences
Prior art date
Application number
DK96910560T
Other languages
Danish (da)
English (en)
Inventor
Tai-An Cha
Richard Spaete
Original Assignee
Medimmune Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Vaccines Inc filed Critical Medimmune Vaccines Inc
Application granted granted Critical
Publication of DK0821693T3 publication Critical patent/DK0821693T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK96910560T 1995-03-31 1996-03-26 Nye DNA-sekvenser fra human cytomegalovirus (HCMV) DK0821693T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/414,926 US5721354A (en) 1995-03-31 1995-03-31 Human cytomegalovirus DNA sequences
PCT/US1996/004100 WO1996030387A1 (fr) 1995-03-31 1996-03-26 Nouvelles sequences d'adn du cytomegalovirus humain

Publications (1)

Publication Number Publication Date
DK0821693T3 true DK0821693T3 (da) 2003-12-22

Family

ID=23643613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96910560T DK0821693T3 (da) 1995-03-31 1996-03-26 Nye DNA-sekvenser fra human cytomegalovirus (HCMV)

Country Status (11)

Country Link
US (7) US5721354A (fr)
EP (1) EP0821693B1 (fr)
JP (1) JP3658411B2 (fr)
AT (1) ATE248184T1 (fr)
AU (1) AU706234B2 (fr)
CA (1) CA2215328C (fr)
DE (1) DE69629674T2 (fr)
DK (1) DK0821693T3 (fr)
ES (1) ES2206569T3 (fr)
PT (1) PT821693E (fr)
WO (1) WO1996030387A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721354A (en) * 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences
FR2762601B3 (fr) * 1997-04-29 1999-06-04 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations
FR2762600B1 (fr) * 1997-04-29 1999-11-05 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utlisations
WO2000034335A2 (fr) * 1998-12-04 2000-06-15 Schering Corporation Genes mammiferes et reactifs connexes
JP3877894B2 (ja) * 1999-01-13 2007-02-07 三菱電機株式会社 車両用ブラシレス交流発電機
JP3581660B2 (ja) 1999-04-30 2004-10-27 ラ ホヤ インスティチュート フォー アラジー アンド イムノロジー 潜伏ウイルスの再活性化を予防しウイルスの複製を制御するための方法
AU1578801A (en) * 1999-11-05 2001-06-06 Human Genome Sciences, Inc. 29 human secreted proteins
GB0024283D0 (en) * 2000-10-04 2000-11-15 Inpharmatica Ltd Novel proteins
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US7204990B1 (en) * 2000-11-28 2007-04-17 Medimmune Vaccines, Inc. Attenuation of cytomegalovirus virulence
AU2002254350A1 (en) * 2001-03-22 2002-10-08 Chandra Arvizu Adenylyl and guanylyl cyclases
AU2003300175A1 (en) * 2002-10-09 2004-05-04 University Of Wales College Of Medicine Hcmv derived immunomodulatory polypeptide
ATE471335T1 (de) * 2002-12-23 2010-07-15 Vical Inc Impfstoffe gegen infektionen mit dem humanen zytomegalivirus auf grundlage von codonoptimierten polynukleotiden
GB0400965D0 (en) * 2004-01-16 2004-02-18 Glaxo Group Ltd Promoter
US8088902B2 (en) 2004-04-05 2012-01-03 The Rockefeller University DNA virus microRNA and methods for inhibiting same
US20080044384A1 (en) * 2004-06-25 2008-02-21 Medlmmune Vaccines, Inc. Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens
US20140348863A1 (en) * 2011-10-12 2014-11-27 Alessia Bianchi Cmv antigens and uses thereof
WO2018005559A1 (fr) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Procédé d'identification d'épitopes peptidiques, molécules qui se lient à de tels épitopes et utilisations associées

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075213A (en) * 1984-07-27 1991-12-24 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US5721354A (en) * 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences

Also Published As

Publication number Publication date
EP0821693A4 (fr) 1999-09-08
ATE248184T1 (de) 2003-09-15
ES2206569T3 (es) 2004-05-16
EP0821693B1 (fr) 2003-08-27
AU706234B2 (en) 1999-06-10
DE69629674D1 (de) 2003-10-02
DE69629674T2 (de) 2004-07-08
JP3658411B2 (ja) 2005-06-08
PT821693E (pt) 2004-01-30
WO1996030387A1 (fr) 1996-10-03
US20060240446A1 (en) 2006-10-26
CA2215328A1 (fr) 1996-10-03
US5721354A (en) 1998-02-24
US6635477B1 (en) 2003-10-21
US20040001850A1 (en) 2004-01-01
CA2215328C (fr) 2011-05-31
EP0821693A1 (fr) 1998-02-04
US5925751A (en) 1999-07-20
US6291236B1 (en) 2001-09-18
JPH11503013A (ja) 1999-03-23
US7208165B2 (en) 2007-04-24
AU5372796A (en) 1996-10-16
US6040170A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DK0821693T3 (da) Nye DNA-sekvenser fra human cytomegalovirus (HCMV)
TR200806258T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
DK0774974T3 (da) Nucleinsyrevaccine
PT757717E (pt) Vacinas de papilomavirus
TR199901571T2 (xx) T�berk�lozun imm�noterapi te�hisi i�in bile�ikler ve y�ntemler.
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
ATE133556T1 (de) Aminosäure-beta-lyase-enzyminhibitoren als deodorantien
NZ504669A (en) Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents
MX9806041A (es) Proteina purificada sr-p70.
EP0857780A4 (fr) Nouvelles proteines s'exprimant specifiquement dans le cancer du foie, genes codant ces proteines, anticorps actifs contre ces proteines et procede de detection de l'expression de ces proteines
SE9602822D0 (sv) New receptor
EP0957936A4 (fr) Formulations de vaccins a base de papillonavirus recombine
FI960427A (fi) Menetelmä prokarioottisten mikro-organismien periplasmassa esiintyvienproteiinien eristämiseksi arginiininläsnä ollessa
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
ZA200006489B (en) Moraxella catarrhalis proteins.
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
CA2177600A1 (fr) Sequences d'acides nucleiques regulatrices et utilisations
KR950702244A (ko) 백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
SE9604439D0 (sv) New receptor
AU2002213725A1 (en) Method for the detection of human hematopoietic short term repopulating cells
DE9319470U1 (de) Mikrobiologisches Nachweissystem
IT239175Y1 (it) Concio in laterizio per la realizzazione di architravi laterocementizi
IL126181A0 (en) Dna sequences proteins coded by them medicaments and detection methods using same